Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
654 |
|
Actual shortage: | 16 (2%) | |
Anticipated shortage: | 6 (1%) | |
Avoided shortage: | 85 (13%) | |
Resolved: | 547 (84%) | |
Discontinuation Reports |
234 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 234 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
83 (9%) |
|
Overdue reports |
2 (9%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MYLAN-ATAZANAVIR | 300MG | CAPSULE | Resolved | 2019-10-15 | 2020-06-26 | 96534 |
MYLAN-BECLO AQ | 50MCG | METERED-DOSE AEROSOL SUSPENSION | Resolved | 2019-10-15 | 2020-03-26 | 96537 |
CLARUS | 10MG | CAPSULE | Resolved | 2019-10-29 | 2020-03-18 | 97440 |
MYLAN-ESCITALOPRAM | 10MG | TABLET | Resolved | 2019-11-12 | 2020-01-29 | 98529 |
MYLAN-ESCITALOPRAM | 20MG | TABLET | Resolved | 2019-11-12 | 2020-01-29 | 98534 |
MYLAN-ACYCLOVIR | 400MG | TABLET | Resolved | 2019-11-12 | 2020-01-17 | 98539 |
MYLAN-VARDENAFIL | Resolved | 2019-11-20 | 2020-06-26 | 99282 | ||
MYLAN-VARDENAFIL | Resolved | 2019-12-06 | 2020-05-20 | 100473 | ||
MYLAN-HYDROXYUREA | 500MG | CAPSULE | Resolved | 2019-12-11 | 2020-06-03 | 100921 |
MYLAN-CILAZAPRIL | 5.0MG | TABLET | Resolved | 2019-12-19 | 2020-07-08 | 101590 |
MYLAN-FINGOLIMOD | 0.5 mg | capsules | Resolved | 2019-12-19 | 2020-03-13 | 101762 |
MYLAN-CILAZAPRIL | 2.5MG | TABLET | Resolved | 2020-01-13 | 2020-07-08 | 103157 |
MYLAN-CILAZAPRIL | 1MG | TABLET | Resolved | 2020-01-13 | 2020-07-15 | 103160 |
MYLAN-AMLODIPINE/ATORVASTATIN | 10MG 80MG | TABLET | Resolved | 2020-01-22 | 2020-04-22 | 103957 |
MYLAN-VERAPAMIL SR | 120MG | TABLET (EXTENDED-RELEASE) | Avoided shortage | 2020-01-23 | 2020-03-25 | 104079 |
CLARUS | 40MG | CAPSULE | Avoided shortage | 2020-01-24 | 2020-01-28 | 104181 |
FREYA 21 | 0.15MG 0.03MG | TABLET | Resolved | 2020-01-28 | 2020-05-06 | 104512 |
MYLAN-MIRTAZAPINE | 45MG | TABLET | Resolved | 2020-01-28 | 2020-02-20 | 104515 |
ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Resolved | 2020-01-28 | 2020-02-12 | 104518 |
ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Resolved | 2020-01-28 | 2020-02-12 | 104521 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MYLAN-MEMANTINE | 10MG | TABLET | Discontinued | 2017-04-12 | 2017-04-13 | 6667 |
MYLAN-METOPROLOL (TYPE L) | 25MG | TABLET | Discontinued | 2017-04-12 | 2017-04-13 | 6670 |
MYLAN-METOPROLOL (TYPE L) | 100MG | TABLET | Discontinued | 2017-04-12 | 2017-04-13 | 6673 |
MYLAN-METOPROLOL (TYPE L) | 50MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6692 |
MYLAN-EZETIMIBE | 10MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6695 |
GEMCITABINE FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Discontinued | 2017-04-13 | 2017-04-13 | 6698 |
GEMCITABINE FOR INJECTION, USP | 2G | POWDER FOR SOLUTION | Discontinued | 2017-04-13 | 2017-04-13 | 6701 |
MYLAN-LEVOFLOXACIN | 250MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6704 |
MYLAN-LEVOFLOXACIN | 500MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6707 |
MYLAN-PRAMIPEXOLE | 0.25MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6710 |
MYLAN-PRAMIPEXOLE | 0.5MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6714 |
MYLAN-PRAMIPEXOLE | 1MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6717 |
MYLAN-PRAMIPEXOLE | 1.5MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6720 |
MYLAN-QUETIAPINE | 25MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6778 |
MYLAN-QUETIAPINE | 100MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6781 |
MYLAN-QUETIAPINE | 200MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6784 |
MYLAN-QUETIAPINE | 300MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6788 |
MYLAN-RAMIPRIL | 1.25MG | CAPSULE | Discontinued | 2017-04-13 | 2017-04-13 | 6792 |
MYLAN-RAMIPRIL | 2.5MG | CAPSULE | Discontinued | 2017-04-13 | 2017-04-13 | 6797 |
MYLAN-RAMIPRIL | 5.0MG | CAPSULE | Discontinued | 2017-04-13 | 2017-04-13 | 6801 |